These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39261819)

  • 21. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
    Li G; Wang X; Liu G
    Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of CCT3 promotes cervical cancer progression through FN1.
    Dou L; Zhang X
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
    Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
    Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
    Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
    Dong Y; Wen W; Yuan T; Liu L; Li X
    Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
    Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
    J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes.
    Liu M; Wei D; Nie Q; Peng L; He L; Cui Y; Ye Y
    Taiwan J Obstet Gynecol; 2022 Jul; 61(4):663-671. PubMed ID: 35779918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of SLC39A4 in the prognosis, immune microenvironment, and contribution to malignant behavior in vivo and in vitro of cervical cancer.
    Zhao YC; Wang TJ; Cui J; She LZ; Zhang RF; Zhang CH
    Transl Oncol; 2024 Feb; 40():101839. PubMed ID: 38029507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer.
    Ma L; Huang W; Liang X; Bai G; Wang X; Jiang H; Xin Y; Hu L; Chen X; Liu C
    Cancer Sci; 2023 Sep; 114(9):3595-3607. PubMed ID: 37438885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma.
    Zhu D; Feng H; Zhang Z; Li J; Li Y; Hou T
    Cancer Med; 2024 Aug; 13(15):e70043. PubMed ID: 39087856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 34. Knockdown of SQLE promotes CD8+ T cell infiltration in the tumor microenvironment.
    Wu J; Hu W; Yang W; Long Y; Chen K; Li F; Ma X; Li X
    Cell Signal; 2024 Feb; 114():110983. PubMed ID: 37993027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
    Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer.
    Brown DN; Caffa I; Cirmena G; Piras D; Garuti A; Gallo M; Alberti S; Nencioni A; Ballestrero A; Zoppoli G
    Sci Rep; 2016 Jan; 6():19435. PubMed ID: 26777065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
    Lin Q; Jiang Y; Zhou F; Zhang Y
    Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100A10 Overexpression Correlates with Adverse Prognosis, Tumor Microenvironment, and Aggressive Behavior
    Zhao YC; Wang TJ; She LZ; Cui J; Zhang CH
    J Cancer; 2023; 14(15):2931-2945. PubMed ID: 37781076
    [No Abstract]   [Full Text] [Related]  

  • 39. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE.
    Sun F; Zhao T
    Cancer Biomark; 2024; 41(2):165-178. PubMed ID: 39331093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.